Last reviewed · How we verify
NCT05625984
Study With Fascigel
NA trial testing Fascigel in Back Pain in 55 participants. Completed in 13 November 2023.
13 November 2023
Quick facts
| Lead sponsor | Contipro Pharma a.s. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 55 |
| Start date | 24 October 2022 |
| Primary completion | 13 November 2023 |
| Estimated completion | 13 November 2023 |
| Sites | 3 locations across Czechia |
Drugs / interventions tested
- Fascigel
Conditions studied
- Back Pain — all drugs for Back Pain →
Sponsor
Contipro Pharma a.s. — full company profile →
Who can join
18 and older, any sex, with Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate polysaccharide in normal saline solution. The device intended use is to help treat back pain by lubricating fascia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05625984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Back Pain
Currently open trials in the same condition.
- NCT07588490 — Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation in Emergency Departments · NA · recruiting
- NCT07292350 — Investigation of the Effects of a Neuromuscular Control-Focused Posture Training Program in Butchers · NA · recruiting
- NCT07319988 — Effect of Shock Wave Therapy With Core Stability Exercises for Treatment of Chronic Non-Specific Back Pain · NA · recruiting
- NCT06655337 — Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) · NA · recruiting
- NCT07104227 — Effects of Body Mechanics Training on Shoulder-Back Pain and Breastfeeding Ergonomics in Breastfeeding Mothers · NA · active not recruiting
Other Contipro Pharma a.s. trials
Trials by the same sponsor.
- NCT07490080 — Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis · terminated
- NCT07065110 — The Effect of Peroral Sodium Hyaluronate on the Skin · NA · completed
- NCT06276270 — Multi-centre, Open-label, First-in-man Study With Mucopad HA · NA · completed
- NCT05618496 — Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients · NA · completed
- NCT04091399 — First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05625984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Contipro Pharma a.s.
- Last refreshed: 7 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05625984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing